Business Wire

LRN and Nordic Business Ethics Initiative to collaborate with the 2023 survey

Share

LRN Corporation, the leader in ethics and compliance solutions that enable organizations to inspire principled performance, today announces a collaboration with the Nordic Business Initiative (NBE) to deliver deeper insights into ethics and compliance (E&C) issues across the Nordic region.

LRN will be the exclusive provider of global E&C benchmarking data to NBE, which will give additional global context to the organization’s bi-annual ‘Nordic Ethics & Compliance Survey’ for the first time.

Nordic Ethics & Compliance Survey reports on trends in the state of ethics & compliance programs in the Nordic region. It analyzes data relating to internal Ethics & Compliance work in Nordic organisations. The survey responses are gathered from Denmark, Finland, Norway and Sweden.

LRN is an authoritative voice on global E&C issues and will provide key data insights and benchmarking from its world-leading 2023 Program Effectiveness Report, as well as previously unpublished insights from its full data set. The report is based on responses from more than 1,850 E&C professionals at organizations across 26 industries and in 10 different countries – the largest and most comprehensive research of its kind.

In addition to providing this extra global perspective to the NBE survey, experts from LRN will also be taking part in an event series alongside prominent speakers from NBE and other leading regional ethics and compliance experts examining the survey findings and exploring key themes and topical issues. The event series will take place after the publication of the full NBE report in November.

“The Nordic Business Ethics Initiative is doing vital work in building awareness of ethics and compliance across the Nordic region, and its research is a critical tool when it comes to understanding the state of play so that key issues can be addressed,” said Kevin Michielsen, CEO of LRN. “Our collaboration with NBE will give this important study a valuable extra dimension. For businesses across the Nordic region, including Nordic-based multi-national companies, it’s important to consider ethics and compliance issues against the global backdrop that takes account of geo-political developments, emerging challenges, and ongoing crises. The incorporation of our global data will help benchmark the performance of companies in the Nordics against their peers around the world and enable even better understanding the impact and efficacy of E&C programs.”

NBE co-founder Niina Ratsula added, “Being able to incorporate insights from LRN’s market-leading dataset into our 2023 Nordic Ethics & Compliance Survey report will give it, and our NBE members, even more value. By putting our findings around what’s happening in the Nordic region into the bigger, international picture, our research will have deeper meaning, so that organizations can see not just how the issues are developing around them, but what’s happening further afield too.”

Companies across the Nordic region are encouraged to participate in this year’s NBE survey by visiting: https://www.nordicbusinessethics.com/nordic-ethics-compliance-survey-2023/.

ENDS

Notes to Editors:

About LRN

LRN's mission and purpose is to inspire principled performance and help people around the world do the right thing. Since 1994, LRN has worked to propel organizations forward with the partnership, knowledge, and tools to build ethical culture. More than 2,800 companies and tens of millions of learners worldwide utilize LRN services and take LRN e-learning courses to help navigate complex regulatory environments and foster ethical, responsible, and inclusive cultures. In partnership with LRN, companies translate their values into concrete corporate practices and leadership behaviors that create sustainable competitive advantage. By acting upon shared values, companies and their people find the means to outbehave and outperform. Learn more at LRN.com and follow on Twitter, LinkedIn, and Facebook.

About the Nordic Business Ethics Initiative

The Nordic Business Ethics Initiative was created to build stronger and more responsible organizations. Its ambition is to promote responsible business conduct and support business leaders and professionals through sharing lessons learned, building best practices and facilitating dialogue and networking. The initiative consists of various activities, all aiming to raise awareness of what business ethics is and provide tools to create ethical, compliant workplaces.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media
Scott Addison, Charlotte Hole and Gabriel Oben, Infinite Global (for LRN Corporation)
LRN@infiniteglobal.com
Niina Ratsula, Co-Founder of Nordic Business Ethics Initiative, niina@nordicbusinessethics.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release

Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release

Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release

Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r

Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr

Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 13:31:00 EET | Press release

The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye